Parallax Volatility Advisers, L.P. 180 Life Sciences Corp. Call Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$2.53 - $3.9 $252,999 - $390,000	-100,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.27 - $6.38 $326,673 - $637,362	-99,900 Reduced 49.97%	100,000 $390,000
Q3 2021 Nov 15, 2021	BUY	$5.11 - $10.81 $766,500 - $1.62 Million	150,000 Added 300.6%	199,900 $1.08 Million
Q2 2021 Aug 16, 2021	SELL	$6.7 - $11.98 $670 - $1,198	-100 Reduced 0.2%	49,900 $499,000
Q1 2021 May 14, 2021	BUY	$2.51 - $6.96 $125,499 - $348,000	50,000 New	50,000 $328,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $141M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.